Voyager Therapeutics, Inc.

VYGR

$2.68

Name : Voyager Therapeutics, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $165,136,112.00

EPSttm : -1.81

Voyager Therapeutics, Inc.

$2.68

4.29%

$0.12

VYGR — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

7.09

Margin Of Safety %

Put/Call OI Ratio

0.12

EPS Next Q Diff

EPS Last/This Y

0.34

EPS This/Next Y

0.43

Price

2.68

Target Price

14.89

Analyst Recom

1.09

Performance Q

-25.35

Upside

-2,463.8%

Beta

1.27

Ticker: VYGR

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	VYGR	3.53	0.27	0.46	8844
2026-08-31	VYGR	3.46	0.28	0.60	8910
2026-09-01	VYGR	3.43	0.27757195782274	0.54084507042254	8966
2026-09-02	VYGR	3.54	0.28	0.30	9048
2026-09-03	VYGR	3.37	0.28	1.14	9118
2026-09-04	VYGR	3.51	0.28	0.04	9136
2026-09-08	VYGR	3.39	0.28	0.00	9133
2026-09-09	VYGR	3.24	0.28	1.11	9192
2026-09-10	VYGR	3.18	0.28	0.36	9266
2026-09-11	VYGR	3.2	0.28	0.53	9304
2026-09-14	VYGR	3.2	0.28	0.47	9330
2026-09-15	VYGR	3.1	0.28	0.49	9381
2026-09-16	VYGR	3.05	0.29	0.00	9352
2026-09-17	VYGR	3.04	0.29	0.00	9351
2026-09-18	VYGR	3.1	0.28	0.30	9450
2026-09-21	VYGR	3.08	0.09	0.08	7399
2026-09-22	VYGR	3.14	0.09	0.02	7536
2026-09-23	VYGR	2.87	0.09	5.33	7573
2026-09-24	VYGR	2.79	0.10	2.93	7639
2026-09-25	VYGR	2.67	0.12	0.70	7738
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	VYGR	3.55	11.1	-	-1.70
2026-08-31	VYGR	3.46	11.1	-	-1.70
2026-09-01	VYGR	3.43	11.1	-	-1.70
2026-09-02	VYGR	3.54	11.1	-	-1.70
2026-09-03	VYGR	3.36	11.1	-	-1.70
2026-09-04	VYGR	3.52	11.1	-	-1.70
2026-09-08	VYGR	3.38	11.1	-	-1.70
2026-09-09	VYGR	3.25	11.1	-	-1.70
2026-09-10	VYGR	3.19	11.1	-	-1.70
2026-09-11	VYGR	3.20	11.1	-	-1.70
2026-09-14	VYGR	3.19	11.1	-	-1.70
2026-09-15	VYGR	3.09	11.1	-	-1.70
2026-09-16	VYGR	3.09	11.1	-	-1.70
2026-09-17	VYGR	3.03	11.1	-	-1.70
2026-09-18	VYGR	3.11	11.1	-	-1.70
2026-09-21	VYGR	3.08	11.1	-	-1.70
2026-09-22	VYGR	3.14	11.1	-	-1.70
2026-09-23	VYGR	2.87	11.1	-	-1.70
2026-09-24	VYGR	2.80	11.1	-	-1.70
2026-09-25	VYGR	2.68	11.1	-	-1.70
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	VYGR	-0.11	0.94	7.68
2026-08-31	VYGR	-0.11	0.93	7.68
2026-09-01	VYGR	-0.11	0.93	7.68
2026-09-02	VYGR	-0.11	0.93	7.68
2026-09-03	VYGR	-0.11	0.93	7.68
2026-09-04	VYGR	-0.11	0.93	7.68
2026-09-08	VYGR	-0.11	0.93	7.68
2026-09-09	VYGR	-0.11	0.93	7.68
2026-09-10	VYGR	-0.11	0.93	7.68
2026-09-11	VYGR	-0.11	0.93	7.34
2026-09-14	VYGR	-0.11	0.94	7.34
2026-09-15	VYGR	-0.11	0.94	7.34
2026-09-16	VYGR	-0.11	0.94	7.34
2026-09-17	VYGR	-0.11	0.94	7.34
2026-09-18	VYGR	-0.11	0.94	7.34
2026-09-21	VYGR	-0.11	0.96	7.34
2026-09-23	VYGR	-0.11	0.96	7.34
2026-09-24	VYGR	-0.11	0.96	7.34
2026-09-25	VYGR	-0.11	0.96	7.09
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

-0.4

Avg. EPS Est. Current Quarter

-0.42

Avg. EPS Est. Next Quarter

-0.4

Insider Transactions

-0.11

Institutional Transactions

0.96

Beta

1.27

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

81.3

Max Drawdown 5-Year %

-80.5

Target Price

14.89

P/E

Forward P/E

PEG

P/S

4.79

P/B

1.06

P/Free Cash Flow

EPS

-1.81

Average EPS Est. Cur. Y

-1.7

EPS Next Y. (Est.)

-1.28

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-312.63

Relative Volume

1.21

Return on Equity vs Sector %

-96.1

Return on Equity vs Industry %

-76.5

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.05

EBIT Estimation

◆ VYGR Healthcare

$2.68

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

5/25

Volume

4/15

Valuation

12/20

TP/AR

2/10

Options

7/10

RSI

26.9

Range 1M

5.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

18/25

Growth

19/30

Estimates

0/20

Inst/Vol

5/15

Options

8/10

EPS Yr

16.5%

EPS NY

23.2%

52W%

1.9%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +455.6% upside

Quality

6/30

Valuation

16/30

Growth

15/25

Stability

7/10

LT Trend

4/5

Upside

+455.6%

Quality

VYGR — P/E HistoricalBiotechnology

Voyager Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 141

Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer's disease. The company also provides research program for the treatment of Huntington's disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small molecules for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia with TDP-43 pathology. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Transition Bio, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.

VYGR

Latest News

—

Caricamento notizie per VYGR…

stock quote shares VYGR – Voyager Therapeutics Inc. Stock Price stock today

news today VYGR – Voyager Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch VYGR – Voyager Therapeutics Inc. yahoo finance google finance

stock history VYGR – Voyager Therapeutics Inc. invest stock market

stock prices VYGR premarket after hours

ticker VYGR fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: VYGR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y